Loading menu…

Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor

§ National Cancer Institute at Frederick

Send Message

To: Author

Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor

Article Fingerprint

ReserarchID

24ZA7

Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background
This converted HTML version may contain rendering inconsistencies. Please refer to the PDF for the authoritative version, or click here to provide feedback.

Abstract

Uterine receptivity needs to be synchronized with embryonic development, so the blastocyst stage of the embryo can implant. Leukemia Inhibitory Factor (LIF) is an essential factor for implantation, which is involved in the initiation of the window of implantation. However, the process by which the LIF signal pathway is transduced in the uterine luminal epithelium (LE) that leads to uterine receptivity is not completely elucidated. We tested the ability of cellular signaling inhibitors to disrupt uterine support of the embryo. Only Tyrphostin-AG490, an inhibitor of Jak2, can interfere with LIF signaling. Not only can AG490 reduce phosphorylated STAT3 levels in isolated LE, but it also ablated implantation when injected into uterine lumen. Furthermore, AG490 treatment in wild-type animals mimics the consequences of genetic ablation of LIF that results in free floating hatched embryos, which are unable to implant. Our results support the notion that Jak2 is the sole Janus kinase to mediate LIF activation in LE, and the signaling pathways of cytokines can serve as contraception targets.

References

22 Cites in Article
  1. 1. B. Paria,H. Song,S. Dey (2001). Implantation: molecular basis of embryo-uterine dialogue. Int J Dev Biol, 45, 597-605.
  2. 2. C. Finn,L. Martin (1974). THE CONTROL OF IMPLANTATION. J Reprod Fertil, 39, 195-206.
  3. 3. J. McCormack,G. Greenwald (1974). PROGESTERONE AND OESTRADIOL-17β CONCENTRATIONS IN THE PERIPHERAL PLASMA DURING PREGNANCY IN THE MOUSE. Journal of Endocrinology, 62(1), 101-107.
  4. 4. J. McCormack,G. Greenwald (1974). EVIDENCE FOR A PREIMPLANTATION RISE IN OESTRADIOL-17β LEVELS ON DAY 4 OF PREGNANCY IN THE MOUSE. J Reprod Fertil, 41, 297-301.
  5. 5. J. Chen,Jr-Gang Cheng,T. Shatzer,L. Sewell,L. Hernandez,C. Stewart (2000). Leukemia Inhibitory Factor Can Substitute for Nidatory Estrogen and Is Essential to Inducing a Receptive Uterus for Implantation But Is Not Essential for Subsequent Embryogenesis1. Endocrinology, 141(12), 4365-4372.
  6. 6. Colin Stewart,Petr Kaspar,Lisa Brunet,Harshida Bhatt,Inder Gadi,Frank Köntgen,Susan Abbondanzo (1992). Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature, 359(6390), 76-79.
  7. 7. Susan Kimber (2005). Leukaemia inhibitory factor in implantation and uterine biology. Reproduction, 130(2), 131-145.
  8. 8. Jr-Gang Cheng,Jim Chen,Lidia Hernandez,W. Alvord,Colin Stewart (2001). Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proceedings of the National Academy of Sciences, 98(15), 8680-8685.
  9. 9. Cheng JG,Rodriguez CI,Stewart CL (2002). Control of Uterine Receptivity and Embryo Implantation by Steroid Hormone Regulation of LIF Production and LIF Receptor Activity: Towards a Molecular Understanding of “The Window of Implantation”. Rev Endocr Metab Disord, 3, 119-126.
  10. 10. Matthias Ernst,Andrew Oates,Ashley Dunn (1996). gp130-mediated Signal Transduction in Embryonic Stem Cells Involves Activation of Jak and Ras/Mitogen-activated Protein Kinase Pathways. Journal of Biological Chemistry, 271(47), 0136-3014.
  11. 11. C. Auernhammer,S. Melmed (2000). Leukemia-Inhibitory Factor—Neuroimmune Modulator of Endocrine Function*. Endocrine Reviews, 21(3), 313-345.
  12. 12. R. Bigsby,P. Cooke,G. Cunha (1986). A simple efficient method for separating murine uterine epithelial and mesenchymal cells. Am J Physiol 251: E, 251
  13. 13. T. Boulton,Z. Zhong,Z. Wen,J. Darnell,N. Stahl,G. Yancopoulos (1995). STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proceedings of the National Academy of Sciences, 92(15), 6915-6919.
  14. 14. M. Narazaki,B. Witthuhn,K. Yoshida,O. Silvennoinen,K. Yasukawa,J. Ihle,T. Kishimoto,T. Taga (1994). Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proceedings of the National Academy of Sciences, 91(6), 2285-2289.
  15. 15. Ernst M,Inglese M,Waring P,Campbell IK,Bao S,Clay FJ,Alexander WS,Wicks IP,Tarlinton DM,Novak U,Heath JK,Dunn AR (2001). Defective Gp130-Mediated Signal Transducer and Activator of Transcription (Stat) Signaling Results in Degenerative Joint Disease, Gastrointestinal Ulceration, and Failure of Uterine Implantation. J Exp Med, 194, 189-203.
  16. 16. Rob Catalano,Martin Johnson,Elizabeth Campbell,D. Charnock-Jones,Stephen Smith,Andrew Sharkey (2005). Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception. Proceedings of the National Academy of Sciences, 102(24), 8585-8590.
  17. 17. Guilluy C,Bregeon J,Toumaniantz G,Rolli- M,Retailleau K,Loufrani L,Henrion D,Scalbert E,Bril A,Torres RM,Offermanns S,Pacaud P,Loirand G (2010). The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nature Medicine, 16(2), 183-190.
  18. 18. Roger Wyatt,Birkett Howarth (1976). Effect of Dimethyl Sulfoxide on Embryonic Survival and Subsequent Chick Performance. Poultry Science, 55(2), 579-582.
  19. 19. C. Finn (1986). IMPLANTATION, MENSTRUATION AND INFLAMMATION. Biological Reviews, 61(4), 313-328.
  20. 20. A. Pardanani (2008). JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials. Leukemia, 22(1), 23-30.
  21. 21. Charnock-Jones DS,Sharkey AM,Fenwick P,Smith SK (1994). Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil, 101, 421-426.
  22. 22. Christine White,Jian-Guo Zhang,Lois Salamonsen,Manuel Baca,W. Fairlie,Donald Metcalf,Nicos Nicola,Lorraine Robb,Evdokia Dimitriadis (2007). Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: A nonhormonal contraceptive strategy. Proceedings of the National Academy of Sciences, 104(49), 9357-1936.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Jrgang Cheng. 2016. "Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor". Global Journal of Medical Research - K: Interdisciplinary GJMR-K Volume 16 (GJMR Volume 16 Issue 9 (K2)).

More Citation Formats

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-K Classification NLMC Code: WP 440
Version of record
v1.2

Issue date
March 21, 2016

Language
English
Order Article Reprint
Experience in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 1.8K
Total Downloads: 101
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor

Jrgang Cheng
Jrgang Cheng National Cancer Institute at Frederick